14-49633745-A-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_018139.3(DNAAF2):​c.1405T>A​(p.Cys469Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00167 in 1,593,752 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C469Y) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 9 hom. )

Consequence

DNAAF2
NM_018139.3 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.995

Publications

3 publications found
Variant links:
Genes affected
DNAAF2 (HGNC:20188): (dynein axonemal assembly factor 2) This gene encodes a highly conserved protein involved in the preassembly of dynein arm complexes which power cilia. These complexes are found in some cilia and are assembled in the cytoplasm prior to transport for cilia formation. Mutations in this gene have been associated with primary ciliary dyskinesia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
DNAAF2 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 10
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043182373).
BP6
Variant 14-49633745-A-T is Benign according to our data. Variant chr14-49633745-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 241280.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0021 (320/152270) while in subpopulation NFE AF = 0.00375 (255/68010). AF 95% confidence interval is 0.00337. There are 0 homozygotes in GnomAd4. There are 155 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 9 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018139.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF2
NM_018139.3
MANE Select
c.1405T>Ap.Cys469Ser
missense
Exon 1 of 3NP_060609.2
DNAAF2
NM_001083908.2
c.1405T>Ap.Cys469Ser
missense
Exon 1 of 2NP_001077377.1
DNAAF2
NM_001378453.1
c.-467T>A
5_prime_UTR
Exon 1 of 2NP_001365382.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF2
ENST00000298292.13
TSL:1 MANE Select
c.1405T>Ap.Cys469Ser
missense
Exon 1 of 3ENSP00000298292.8
DNAAF2
ENST00000406043.3
TSL:1
c.1405T>Ap.Cys469Ser
missense
Exon 1 of 2ENSP00000384862.3

Frequencies

GnomAD3 genomes
AF:
0.00210
AC:
320
AN:
152152
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00405
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00375
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00178
AC:
414
AN:
232926
AF XY:
0.00162
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000215
Gnomad ASJ exome
AF:
0.00365
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00469
Gnomad NFE exome
AF:
0.00269
Gnomad OTH exome
AF:
0.000888
GnomAD4 exome
AF:
0.00163
AC:
2347
AN:
1441482
Hom.:
9
Cov.:
92
AF XY:
0.00166
AC XY:
1185
AN XY:
715892
show subpopulations
African (AFR)
AF:
0.0000910
AC:
3
AN:
32964
American (AMR)
AF:
0.000211
AC:
9
AN:
42716
Ashkenazi Jewish (ASJ)
AF:
0.00405
AC:
102
AN:
25170
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39510
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84820
European-Finnish (FIN)
AF:
0.00553
AC:
262
AN:
47394
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5676
European-Non Finnish (NFE)
AF:
0.00169
AC:
1866
AN:
1103690
Other (OTH)
AF:
0.00176
AC:
105
AN:
59542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
162
324
487
649
811
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00210
AC:
320
AN:
152270
Hom.:
0
Cov.:
33
AF XY:
0.00208
AC XY:
155
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41560
American (AMR)
AF:
0.000458
AC:
7
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00405
AC:
43
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00375
AC:
255
AN:
68010
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00272
Hom.:
4
Bravo
AF:
0.00147
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00129
AC:
11
ExAC
AF:
0.00165
AC:
200

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Primary ciliary dyskinesia (2)
-
1
1
Primary ciliary dyskinesia 10 (2)
-
-
1
DNAAF2-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.024
DANN
Benign
0.46
DEOGEN2
Benign
0.00052
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.27
T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.99
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.010
Sift
Benign
0.46
T
Sift4G
Benign
0.63
T
Polyphen
0.0
B
Vest4
0.047
MutPred
0.30
Gain of catalytic residue at G465 (P = 5e-04)
MVP
0.095
MPC
0.63
ClinPred
0.012
T
GERP RS
-2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.064
gMVP
0.30
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202079418; hg19: chr14-50100463; COSMIC: COSV106101255; COSMIC: COSV106101255; API